[EN] SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1<br/>[FR] AGONISTES À PETITES MOLÉCULES DE RÉCEPTEUR DE NEUROTENSINE 1
申请人:SANFORD BURNHAM MED RES INST
公开号:WO2014100501A1
公开(公告)日:2014-06-26
Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
A highly efficient heterogeneous copper-catalyzed cascade reaction of 2-halobenzoic acids and amidines leading to quinazolinones
作者:Wen He、Hong Zhao、Ruiya Yao、Mingzhong Cai
DOI:10.1039/c4ra09379h
日期:——
The heterogeneous cascade reaction of 2-halobenzoic acids and amidines was achieved in DMF at 60 °C in the presence of 10 mol% of MCM-41-immobilized tridentate nitrogen copper(I) complex [MCM-41-3N–CuI] using Cs2CO3 as base, yielding a variety of quinazolinone derivatives in good to excellent yields. This heterogeneous copper catalyst can be easily prepared from commercially available and inexpensive
2-卤代苯甲酸和am的级联反应是在60°C的DMF中,使用Cs在10 mol%的MCM-41固定的三齿氮铜(I)络合物[MCM-41-3N–CuI]存在下完成的以2 CO 3为碱,以良好或优异的产率生成各种喹唑啉酮衍生物。这种多相铜催化剂可以容易地由市售和廉价的试剂制备,并通过对反应溶液的简单过滤来回收,并且在不降低活性的情况下重复使用至少10次。
A Simple and Efficient Approach to Quinazolinones under Mild Copper-Catalyzed Conditions
作者:Xiaowei Liu、Hua Fu、Yuyang Jiang、Yufen Zhao
DOI:10.1002/anie.200804675
日期:2009.1.2
Cop somerings: A simple and highly efficient copper‐catalyzed method for the synthesis of quinazolinone derivatives through the reaction of substituted2‐halobenzoic acids with amidines or guanidines under mild conditions has been developed (see scheme). The method has economical and practical advantages.
Transition-metal free synthesis of quinazolinones via tandem cyclization of 2-halobenzoic acids with amidines
作者:Abhishek R. Tiwari、Bhalchandra M. Bhanage
DOI:10.1039/c5ra11159e
日期:——
A simple protocol for the synthesis of quinazoline-4(3H)-ones by tandem cyclization of 2-halobenzoic acids with amidines has been developed by using KOH as a base in DMSO at 120 °C.
Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.